Morgan Stanley: Market's Reaction To Linger For Alexion Pharmaceuticals
May 07, 2015 at 16:03 PM EDT
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) shares are likely to suffer lingering ill effects from its $8.4 billion plan to acquire ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.